// App-Quantinova.ai

2193 : The Spectrum Of Cold Agglutinin Disease At The Era Of Rituximab: A Retrospective Study On 48 Patients

Researchers

Presenter

  • Mathilde Lamarque

Principal Investigators

  • Veronique Leblond

  • Bruno R. Varet

  • Sylvain Choquet

  • Jean Paul Vernant

  • Richard Delarue

  • Bertrand Godeau

  • Olivier Hermine

  • Marc Michel IV

Medical Centers

  • Hematology Dept., Paris Descartes Univ. Necker Hospital, Paris, France

  • Internal Medicine, Hopital Henri Mondor, Creteil, France

  • Department of Internal Medicine - National Referential Center of AutoImmune Cytopenia, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris Est Creteil University, Creteil, France

  • National Reference Center fo Adult Autoimmune Cytopenia, Henri Mondor Hospital, Paris Est Creteil University, Creteil, France

  • Hematology, Hopital Pitie-Salptriere, Paris, France

  • Rheumatology Department, AP-HP, Hopital Pitie Salpetriere, Paris, France

  • Service dHematologie Biologique, APHP La Pitie-Salpetriere, Paris, France

  • Service -Hematologie, AP-HP, Hopital Necker, Paris, France

  • Hematology Department, Necker Hospital, Paris, France

  • Departement dHematologie, Hopital de la Pitie-Salpetriere, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Diffuse large B-cell lymphoma

  • Chronic Lymphocytic Leukemia

  • Lympho proliferative disease

  • Mucosa-associated lymphoid tissue lymphoma

  • Follicular lymphoma

  • Venous thrombosis

  • B cell lymphomas

  • Peripheral neuropathy

  • Hyperbilirubinemia

  • Lymphomas

  • Anemia

  • Sepsis

  • Chronic obstructive pulmonary disease

Biomarkers

  • Epithelial Cell Adhesion Molecule

  • Estrogen receptor alpha

  • Immunoglobulin G

Drug/Treatment

  • Oraprine

  • FA-8

  • Rituximab

  • Danazol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved